Neurocognitive consequences of a paediatric brain tumour and its treatment: A meta-analysis

Developmental Medicine and Child Neurology

Volumn 55, Issue 5, 2013, Pages 408-417

  De Ruiter, Marieke A ^a   Van Mourik, Rosa ^b   Schouten Van Meeteren, Antoinette Y N ^a   Grootenhuis, Martha A ^a   Oosterlaan, Jaap ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT TOOL; ERROR; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; MENTAL PERFORMANCE; META ANALYSIS; PRIORITY JOURNAL; REACTION TIME; REVIEW; SCORING SYSTEM; SURVIVOR; SYSTEMATIC REVIEW; VERBAL COMMUNICATION; WECHSLER INTELLIGENCE SCALE;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; COGNITION DISORDERS; DATABASES, FACTUAL; FEMALE; HUMANS; INTELLIGENCE; INTELLIGENCE TESTS; MALE; PEDIATRICS; REGRESSION ANALYSIS;

EID: 84876196805     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12020     Document Type: Review

References (72)

1. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev 2010; 36: 277-85.
2. Mariotto AB, Rowland JH, Yabroff KR, et al.Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev 2009; 18: 1033-40.
3. Ries LAG, Melbert D, Krapcho M, et al.SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute, 2008.
4. Butler RW, Mulhern RK. Neurocognitive interventions for children and adolescents surviving cancer. J Pediatr Psychol 2005; 30: 65-78.
5. Duffner PK. Risk factors for cognitive decline in children treated for brain tumors. Eur J Paediatr Neurol 2010; 14: 106-15.
6. Bhat SR, Goodwin TL, Burwinkle TM, et al.Profile of daily life in children with brain tumors: an assessment of health-related quality of life. J Clin Oncol 2005; 23: 5493-500.
7. Koch SV, Kejs AM, Engholm G, Johansen C, Schmiegelow K. Educational attainment among survivors of childhood cancer: a population-based cohort study in Denmark. Br J Cancer 2004; 91: 923-8.
8. Zebrack BJ, Gurney JG, Oeffinger K, et al.Psychological outcomes in long-term survivors of childhood brain cancer: a report from the childhood cancer survivor study. J Clin Oncol 2004; 22: 999-1006.
9. Grill J, Renaux VK, Bulteau C, et al.Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 1999; 45: 137-45.
10. Conklin HM, Li C, Xiong X, Ogg RJ, Merchant TE. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J Clin Oncol 2008; 26: 3965-70.
11. Rutkowski S, Bode U, Deinlein F, et al.Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005; 352: 978-86.
12. Patel SK, Mullins WA, O'Neil SH, Wilson K. Neuropsychological differences between survivors of supratentorial and infratentorial brain tumours. J Intellect Disabil Res 2011; 55: 30-40.
13. Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. J Clin Oncol 2001; 19: 3470-6.
14. Palmer SL, Goloubeva O, Reddick WE, et al.Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. J Clin Oncol 2001; 19: 2302-8.
15. Conners CK. Conners' Continuous Performance Test (CPT). Toronto, Canada: Multi-Health Systems, 1995.
16. Conners CK. Conners' Continuous Performance Test (CPT II). New York: Multi-Health System, 2002.
17. Wechsler D. Wechsler's Intelligence Scale for Children, 3rd edn. London: Harcourt Brace, 1992.
18. Hardy KK, Willard VW, Bonner MJ. Computerized cognitive training in survivors of childhood cancer: a pilot study. J Pediatr Oncol Nurs 2011; 28: 27-33.
19. O'Neil S, Ji LY, Buranahirun C, et al.Neurocognitive outcomes in pediatric and adolescent patients with central nervous system germinoma treated with a strategy of chemotherapy followed by reduced-dose and volume irradiation. Pediatr Blood Cancer 2011; 57: 669-73.
20. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms and Commentary, 3rd edn. New York, NY: Oxford University Press, 2006.
21. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analysis. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed 1 November 2011).
22. Borenstein M, Rothstein H. Comprehensive Meta-Analysis, A Computer Program for Research Synthesis, 2nd edn. Englewood, NJ: Biostat, 1999.
23. Jalali R, Goswami S, Sarin R, More N, Siddha M, Kamble R. Neuropsychological status in children and young adults with benign and low-grade brain tumors treated prospectively with focal stereotactic conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66: S14-9.
24. Lacaze E, Kieffer V, Streri A, et al.Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy. Br J Cancer 2003; 89: 2038-44.
25. Merchant TE, Sherwood SH, Mulhern RK, et al.CNS germinoma: disease control and long-term functional outcome for 12 children treated with craniospinal irradiation. Int J Radiat Oncol Biol Phys 2000; 46: 1171-6.
26. Ris MD, Beebe DW, Armstrong FD, et al.Cognitive and adaptive outcome in extracerebellar low-grade brain tumors in children: a report from the Children's Oncology Group. J Clin Oncol 2008; 26: 4765-70.
27. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13.
28. Cohen J. The statistical power of abnormal-social psychological research: a review. J Abnorm Soc Psychol 1962; 65: 145-53.
29. Aukema EJ, Caan MW, Oudhuis N, et al.White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int J Radiat Oncol Biol Phys 2009; 74: 837-43.
30. Gliner JA, Morgan GA, Harmon RJ. Meta-analysis: formulation and interpretation. J Am Acad Child Adolesc Psychiatry 2003; 42: 1376-9.
31. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?Psychol Methods 2006; 11: 193-206.
32. Conklin HM, Khan RB, Reddick WE, et al.Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediatr Psychol 2007; 32: 1127-39.
33. Mulhern RK, Palmer SL, Reddick WE, et al.Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol 2001; 19: 472-9.
34. Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 2004; 22: 706-13.
35. Rosenthal R. Writing meta-analytic reviews. Psychol Bull 1995; 118: 183-92.
36. Saury JMG, Emanuelson I. Cognitive consequences of the treatment of medulloblastoma among children. Pediatr Neurol 2011; 44: 21-30.
37. Sands SA, Oberg JA, Gardner SL, Whiteley JA, Glade-Bender JL, Finlay JL. Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the head start II survivors. Pediatr Blood Cancer 2010; 54: 429-36.
38. Bonner MJ, Hardy KK, Willard VW, Gururangan S. Additional evidence of a nonverbal learning disability in survivors of pediatric brain tumors. Childrens Health Care 2009; 38: 49-63.
39. Callu D, Viguier D, Laroussinie F, et al.Cognitive and academic outcome after benign or malignant cerebellar tumor in children. Cogn Behav Neurol 2009; 22: 270-8.
40. Briere ME, Scott JG, McNall-Knapp RY, Adams RL. Cognitive outcome in pediatric brain tumor survivors: delayed attention deficit at long-term follow-up. Pediatr Blood Cancer 2008; 50: 337-40.
41. Sanders RP, Kocak M, Burger PC, Merchant TE, Gajjar A, Broniscer A. High-grade astrocytoma in very young children. Pediatr Blood Cancer 2007; 49: 888-93.
42. Khong PL, Leung LH, Fung AS, et al.White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J Clin Oncol 2006; 24: 884-90.
43. Beebe DW, Ris MD, Armstrong FD, et al.Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130). J Clin Oncol 2005; 23: 5198-204.
44. Grill J, Viguier D, Kieffer V, et al.Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage. J Neurosurg 2004; 101: 152-8.
45. Packer RJ. Radiation-induced neurocognitive decline: the risks and benefits of reducing the amount of whole-brain irradiation. Curr Neurol Neurosci Rep 2002; 2: 131-3.
46. Carey ME, Barakat LP, Foley B, Gyato K, Phillips PC. Neuropsychological functioning and social functioning of survivors of pediatric brain tumors: evidence of nonverbal learning disability. Child Neuropsychol 2001; 7: 265-72.
47. Kieffer-Renaux V, Bulteau C, Grill J, Kalifa C, Viguier D, Jambaque I. Patterns of neuropsychological deficits in children with medulloblastoma according to craniospatial irradiation doses. Dev Med Child Neurol 2000; 42: 741-5.
48. Mulhern RK, Reddick WE, Palmer SL, et al.Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol 1999; 46: 834-41.
49. Hazin I, Dellatolas G, Garcia D, Pedrosa F, Pedrosa A. Intellectual Impairment after treatment for medulloblastoma and astrocytoma in childhood: the Brazilian experience. J Pediatr Hematol Oncol 2011; 33: 506-15.
50. Butler RW, Copeland DR, Fairclough DL, et al.A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol 2008; 76: 367-78.
51. Mabbott DJ, Penkman L, Witol A, Strother D, Bouffet E. Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology 2008; 22: 159-68.
52. Stargatt R, Rosenfeld JV, Maixner W, Ashley D. Multiple factors contribute to neuropsychological outcome in children with posterior fossa tumors. Dev Neuropsychol 2007; 32: 729-48.
53. Reeves CB, Palmer SL, Reddick WE, et al.Attention and memory functioning among pediatric patients with medulloblastoma. J Pediatr Psychol 2006; 31: 272-80.
54. Mulhern RK, White HA, Glass JO, et al.Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood. J Int Neuropsychol Soc 2004; 10: 180-9.
55. Deary I, Strand S, Smith P, Fernandes C. Intelligence and educational achievement. Intelligence 2007; 35: 13-21.
56. Watkins MW, Lei P, Canivez GL. Psychometric intelligence and achievement: a cross-lagged panel analysis. Intelligence 2007; 35: 59-68.
57. Reddick WE, White HA, Glass JO, et al.Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer 2003; 97: 2512-9.
58. de Boer AG, Verbeek JH, van Dijk FJ. Adult survivors of childhood cancer and unemployment: a metaanalysis. Cancer 2006; 107: 1-11.
59. Anderson V, Northam E, Hendy J, Wrennall J. Developmental Neuropsychology; A Clinical Approach. Hove, East Sussex: Psychology Press, 2001.
60. Johnson S. Cognitive and behavioural outcomes following very preterm birth. Semin Fetal Neonatal Med 2007; 12: 363-73.
61. Cantelmi D, Schweizer TA, Cusimano MD. Role of the cerebellum in the neurocognitive sequelae of treatment of tumours of the posterior fossa: an update. Lancet Oncol 2008; 9: 569-76.
62. Salman MS. The cerebellum: it's about time! But timing is not everything-new insights into the role of the cerebellum in timing motor and cognitive tasks. J Child Neurol 2002; 17: 1-9.
63. Copeland DR, deMoor C, Moore BD III, Ater JL. Neurocognitive development of children after a cerebellar tumor in infancy: a longitudinal study. J Clin Oncol 1999; 17: 3476-86.
64. Monje M, Dietrich J. Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behav Brain Res 2012; 227: 376-9.
65. Dockstader C, Gaetz W, Rockel C, Mabbott DJ. White matter maturation in visual and motor areas predicts the latency of visual activation in children. Hum Brain Mapp 2012; 33: 179-91.
66. Dennis M, Hetherington CR, Spiegler BJ. Memory and attention after childhood brain tumors. Med Pediatr Oncol 1998; 30 (Suppl. 1) 25-33.
67. Netson KL, Conklin HM, Ashford JM, Kahalley LS, Wu S, Xiong X. Parent and teacher ratings of attention during a year-long methylphenidate trial in children treated for cancer. J Pediatr Psychol 2011; 36: 438-50.
68. Kahalley LS, Conklin HM, Tyc VL, et al.ADHD and secondary ADHD criteria fail to identify many at-risk survivors of pediatric ALL and brain tumor. Pediatr Blood Cancer 2011; 57: 110-8.
69. Kiehna EN, Mulhern RK, Li C, Xiong X, Merchant TE. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol 2006; 24: 5283-90.
70. Rubia K, Smith AB, Brammer MJ, Taylor E. Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection. Neuroimage 2003; 20: 351-8.
71. Han R, Yang YM, Dietrich J, Luebke A, Mayer-Proschel M, Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol 2008; 7: 12.
72. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004; 5: 399-408.